Table 1 Patients’ characteristics
From: Prognostic factors in patients with thymoma who underwent surgery
Characteristic | Number | Percent |
|---|---|---|
Total patients | 137 | 100 |
Age (years) | ||
Median | 57 | |
Range | 29–87 | |
Gender | ||
Male | 64 | 46.7 |
Female | 73 | 53.3 |
KPS | ||
≥ 80 | 128 | 93.5 |
< 80 | 9 | 6.5 |
Smoking status | ||
Current | 37 | 27.0 |
Former/never | 100 | 73.0 |
Myasthenia gravis | ||
Yes | 36 | 26.3 |
No | 101 | 73.7 |
Surgical approach | ||
Open | 56 | 40.9 |
VATS | 81 | 59.1 |
Tumor size | ||
≥ 6 cm | 54 | 39.4 |
< 6 cm | 83 | 60.6 |
Pericardium invasion | ||
Yes | 39 | 28.4 |
No | 98 | 71.6 |
Lung invasion | ||
Yes | 34 | 24.8 |
No | 103 | 75.2 |
Resection status | ||
R0 | 85 | 62.0 |
Non-R0 | 52 | 38.0 |
WHO classification | ||
A | 7 | 5.1 |
AB | 33 | 24.1 |
B1 | 33 | 24.1 |
B2 | 37 | 27.0 |
B3 | 14 | 10.2 |
Thymic carcinoma | 13 | 9.5 |
Masaoka-Koga stage | ||
I | 70 | 51.1 |
II | 12 | 8.8 |
III | 37 | 27.0 |
IV | 18 | 13.1 |
Ki-67 | ||
≥ 60% | 85 | 62.0 |
< 60% | 52 | 38.0 |
Neutrophil | ||
≥ 3.62 | 57 | 41.6 |
< 3.62 | 80 | 58.4 |
NLR | ||
≥ 2.85 | 25 | 18.2 |
< 2.85 | 112 | 81.8 |
Adjuvant radiotherapy | ||
Yes | 60 | 43.8 |
No | 77 | 56.2 |
Adjuvant chemotherapy | ||
Yes | 27 | 19.7 |
No | 110 | 80.3 |